Andere Sprachen Ikena Oncology, Inc.

Aktien

A2QRZ9

US45175G1085

IKNA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 01.05.2024			% 5 Tage	% 1. Jan.
1,3 ^USD	-1,52 %		+0,78 %	-34,01 %

12.03.	Ikena Oncology, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
21.02.	Ikena Oncology, Inc. kündigt Änderungen in der Geschäftsführung an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ikena Oncology : Corporate Presentation - April 2024	16.04.
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum	10.04.
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum	10.04.
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results	12.03.
Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	12.03.
North American Morning Briefing : Inflation Data -2-	12.03.
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference	27.02.
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer	21.02.
Ikena Oncology, Inc. Announces Executive Changes	21.02.
Ikena Oncology to Cut 35% of Workforce to Extend Cash Runway Into H2 2026	18.01.
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates	18.01.
Ikena Oncology, Inc. Provides Corporate Updates	18.01.
Top Premarket Decliners	24.11.
Ikena Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results	09.11.
Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results	09.11.
Ikena Oncology, Inc. Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial	09.11.
Ikena Oncology to Present at Multiple November 2023 Investor Conferences	07.11.
Ikena Oncology to Present at Multiple November 2023 Investor Conferences	07.11.
North American Morning Briefing : Stocks Look to -2-	06.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ikena Oncology, Inc.

Aktien

A2QRZ9

US45175G1085

IKNA

Andere Sprachen

Filter